103 related articles for article (PubMed ID: 7778301)
1. Analysis of ALV-based packaging cell lines for production of contaminant defective viruses.
Girod A; Cosset FL; Verdier G; Ronfort C
Virology; 1995 Jun; 209(2):671-5. PubMed ID: 7778301
[TBL] [Abstract][Full Text] [Related]
2. Defective retroviral endogenous RNA is efficiently transmitted by infectious particles produced on an avian retroviral vector packaging cell line.
Ronfort C; Girod A; Cosset FL; Legras C; Nigon VM; Chebloune Y; Verdier G
Virology; 1995 Feb; 207(1):271-5. PubMed ID: 7871738
[TBL] [Abstract][Full Text] [Related]
3. Analysis of retroviral assembly using a vaccinia/T7-polymerase complementation system.
Dong J; Hunter E
Virology; 1993 May; 194(1):192-9. PubMed ID: 8386872
[TBL] [Abstract][Full Text] [Related]
4. A new defective retroviral vector system based on the Bryan strain of Rous sarcoma virus.
Boerkoel CF; Federspiel MJ; Salter DW; Payne W; Crittenden LB; Kung HJ; Hughes SH
Virology; 1993 Aug; 195(2):669-79. PubMed ID: 8393241
[TBL] [Abstract][Full Text] [Related]
5. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
6. Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments.
Markowitz DG; Goff SP; Bank A
Trans Assoc Am Physicians; 1988; 101():212-8. PubMed ID: 3077729
[TBL] [Abstract][Full Text] [Related]
7. Virofection: a one-step procedure for using replication-defective retrovirus vectors.
Flamant F; Samarut J
Virology; 1995 Aug; 211(1):234-40. PubMed ID: 7645216
[TBL] [Abstract][Full Text] [Related]
8. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
11. Detection of osteoclastic cell-cell fusion through retroviral vector packaging.
Kondo T; Ikeda K; Matsuo K
Bone; 2004 Nov; 35(5):1120-6. PubMed ID: 15542037
[TBL] [Abstract][Full Text] [Related]
12. The spread of a replication-competent MuLV retroviral vector can be efficiently blocked by deletion variants.
Nouvel P; Panthier JJ; Condamine H
Virology; 1994 Oct; 204(1):180-9. PubMed ID: 8091651
[TBL] [Abstract][Full Text] [Related]
13. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner.
Rizvi TA; Schmidt RD; Lew KA
Virology; 1997 Sep; 236(1):118-29. PubMed ID: 9299624
[TBL] [Abstract][Full Text] [Related]
14. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV
Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671
[TBL] [Abstract][Full Text] [Related]
15. Effects of the gag region on genome stability: avian retroviral vectors that contain sequences from the Bryan strain of Rous sarcoma virus.
Federspiel MJ; Hughes SH
Virology; 1994 Sep; 203(2):211-20. PubMed ID: 8053145
[TBL] [Abstract][Full Text] [Related]
16. Use of helper cells with two host ranges to generate high-titer retroviral vectors.
Cosset FL; Girod A; Flamant F; Drynda A; Ronfort C; Valsesia S; Molina RM; Faure C; Nigon VM; Verdier G
Virology; 1993 Mar; 193(1):385-95. PubMed ID: 8382402
[TBL] [Abstract][Full Text] [Related]
17. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
18. Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication.
Rizvi TA; Ali J; Phillip PS; Ghazawi A; Jayanth P; Mustafa F
Virology; 2009 Mar; 385(2):464-72. PubMed ID: 19157480
[TBL] [Abstract][Full Text] [Related]
19. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
20. Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection.
Huang Y; Zhang L; Ho DD
Virology; 1998 Jan; 240(1):36-49. PubMed ID: 9448687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]